L’Oréal Groupe’s Dermatological Beauty Division has unveiled the next phase of its €20m L’Oréal Act for Dermatology initiative with the World Health Organization (WHO) Foundation at the European Academy of Dermatology & Venereology (EADV) Congress, with the first major projects now coming to life.
Six months on from its initial launch, the first early findings from the beauty giant’s Act for Dermatology programme have been revealed, which is dedicated to increasing access to skin health worldwide.
The group’s Global Observatory for Skin Health study has unveiled the first early findings of its first-ever assessment of dermatological care access in more than 190 countries.
The study aims to ensure dermatology is recognised, prioritised and resourced as an indispensable part of global health as 2.1 billion people worldwide are now living with skin conditions.
L’Oréal Dermatological Beauty shared these early findings at the EADV Congress, which is happening in Paris, France, from 17 to 20 September – a leading scientific gathering for skin health.
This news was shared alongside the debut of L’Oréal-owned brand Vichy’s debut into longevity beauty with two products that address ‘hair longevity’ and skin volume loss.
“It is an incredibly exciting time,” Sophie Dumortier, Chief Medical Officer, L’Oréal Dermatological Beauty, told Cosmetics Business.
“The very first major project emerging from our L’Oréal Act for Dermatology initiative is the Global Access to Skin Health Observatory, a significant partnership with the International Leagues for Dermatology (ILDS).
“We launched it in October 2024, and it is truly groundbreaking – the first-ever comprehensive study to map out access to dermatological care across over 190 countries worldwide.”
L’Oréal Dermatological Beauty said the importance of the Global Access to Skin Health Observatory study is “profound” as WHO officially recognised skin health as a global public health priority earlier this year.
“Equitable access to skin health is not just a privilege, it is a fundamental right,” said Dumortier.
“The Global Observatory for Skin Health study will be the engine for systemic change, it will give us an unparalleled, detailed picture of the global dermatological landscape.
“Our aim is clear: to ensure dermatology gets the recognition, prioritisation and resources it desperately needs as an indispensable part of global health.
“Ultimately, closing those existing gaps in care.”
Early findings from L’Oréal Dermatological Beauty’s Global Observatory for Skin Health study
The French beauty group’s research has been undertaken to understand the global reality of dermatological care to help drive change, secure proper recognition for dermatology and ensure better access for all.
“Our early findings are already shedding light on some important areas,” said Dumortier.
“This comprehensive, country-level data is foundational for our L’Oréal Act for Dermatology initiative, to make skin health more accessible and equitable for everyone, everywhere.”
The first early findings were presented at EADV with four dedicated posters – dermatologist availability, common skin conditions, barriers to care and access to treatments.
In the ‘Dermatologist Availability’ poster, the first early findings found
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.